Health product recall

DCA Vantage® HbA1c (DX Claim)

Last updated

Summary

Product
DCA Vantage® HbA1c (DX Claim)
Issue
Medical devices - Performance
What to do

Contact the manufacturer if you require additional information.

Affected products

Affected products Lot or serial number Model or catalogue number
DCA Vantage® HbA1c (DX Claim) 0916065 10698915

Issue

Siemens Healthineers has confirmed through customer complaint investigation and internal testing that delamination of the buffer pull-tab may occur in a small subset of cartridges. Delamination occurs when bonded material layers within the pull-tab separate, preventing full release of the buffer solution into the reaction chamber and reducing the reagent volume available for analysis.
When delamination occurs, it may result in falsely low (negatively biased) HbA1c results or instrument-generated error codes that prevent completion of the test. The issue observed in approximately 0.07-0.5% of cartridges in these lots. The majority of the cartridges in these lots continue to perform as intended.

Additional information

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Medical devices - Haematology
Companies

Siemens Healthcare Diagnostics Inc.

511 Benedict Ave, Tarrytown, New York, United States, 10591

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Recall date
Identification number
RA-82378

Get notified

Receive emails about new and updated recall and safety alerts.

Subscribe